EarningsHaleon's global leadership in core categories and therapeutic oral care provides opportunities for category penetration and growth in emerging markets.
Financial PerformanceHaleon has strong cash conversion and quick deleveraging, leading to a healthy EPS CAGR of approximately 7.6%.
Market PositionHaleon's portfolio of Power Brands outperformed delivering +5.6% growth, as 69% of the total portfolio maintained or gained share, a record versus UK Staples peers.